The endovascular treatment of middle cerebral artery (MCA) aneurysms with unfavorable anatomy (wide neck, unfavorable morphology) is frequently challenging. Flow disruption with the WEB is a potentially interesting endovascular treatment for this type of aneurysm. OBJECTIVE: To report in a multicenter series the preliminary treatment experience of MCA aneurysms with flow disruption by the WEB. METHODS: Thirty-three patients with 34 MCA aneurysms were treated with the WEB in 5 European centers. The ability to successfully deploy the WEB, procedure-and devicerelated adverse events, morbidity and mortality of the treatment, and short-term angiographic follow-up results were analyzed. RESULTS: Most treated aneurysms were unruptured (85.3%) and were between 5 and 10 mm (85.3%) with a neck size $ 4 mm (88.2%). The treatment failed in 1 of the 34 aneurysms (2.9%) owing to a lack of appropriate device size. Treatment was performed exclusively with the WEB in 29 of 33 aneurysms (87.9%). Additional treatment (coiling and/or stenting) was used in 4 of 33 aneurysms (12.1%). Mortality of the treatment was 0.0% and morbidity was 3.1% (intraoperative rupture with modified Rankin Scale score of 3 at the 1-month follow-up). In short-term follow-up (range, 2-12 months), adequate occlusion (total occlusion or neck remnant) was observed in 83.3% of aneurysms. CONCLUSION: WEB flow disruption seems to be a promising technique for the treatment of complex MCA aneurysms, particularly those with a wide neck or unfavorable dome-to-neck ratio.
onstrated the broad utility of aneurysm coiling in the management of both ruptured and unruptured aneurysms. [1] [2] [3] [4] In most of these series, no subgroup analysis was available to determine whether clinical outcome was different according to aneurysm location. [2] [3] [4] In ISAT, the number of middle cerebral artery (MCA) aneurysms was relatively small (303 aneurysms), but the subgroup analyses showed that death or dependency at 1 year was not affected by aneurysm location. 5 However, the location of endovascular treatment, especially in MCA aneurysms, is still a matter of debate; long-term follow-up data of the ISAT showed that the proportion of survivors at 5 years who were independent did not differ between the 2 groups: 83% for endovascular treatment and 82% for neurosurgical treatment (but the risk of death was significantly lower in the coiling group compared with the clipping group). 6 Endovascular treatment is also associated with a relatively high rate of aneurysm recanalization (20.8%), leading to aneurysm retreatment in 10.3% of patients. 7 In some aneurysms, coiling is simply impossible because of the aneurysm shape, particularly when the neck is wide. For these specific situations, new endovascular techniques like remodeling technique or flow diversion have been developed, reducing the number of situations in which endovascular treatment is impossible. 8, 9 The debate is heightened for MCA aneurysms because they are considered favorable for clipping because of their accessibility and may be difficult to coil because of the frequently complex anatomy of MCA trifurcation and frequent broad base of the aneurysm. A limited number of recent series analyzed the surgical results for MCA aneurysms. [10] [11] [12] Several series have shown that endovascular treatment of MCA aneurysms is feasible and effective in selected cases. [13] [14] [15] [16] [17] Because they are often wide necked, endovascular treatment of MCA aneurysms by coiling alone is not always feasible, and an unmet need exists for an endovascular approach.
WEB flow disruption is a new technique using an intraaneurysmal device to disrupt the intra-aneurysmal flow and subsequently create intra-aneurysmal (and intradevice) thrombosis. Clinical results were previously reported with the WEB device and showed high feasibility of treatment, good safety, and acceptable short-term anatomic results. [18] [19] [20] The goal of the present study is to analyze the feasibility, safety, and efficacy of WEB flow disruption in the treatment of MCA aneurysms.
PATIENTS AND METHODS

Objective
The goal of this retrospective, multicenter clinical series is to assess the feasibility, safety, and short-term and midterm efficacy of the endovascular treatment of MCA aneurysms by WEB flow disruption.
Patient Selection
The study received Institutional Review Board approval in the 5 participating centers. In each center, indication for treatment and its modality (surgery or endovascular treatment) were decided on a caseby-case basis by a local multidisciplinary team including neurosurgeons, neuroanesthesiologists, neurologists, and neuroradiologists. The selection of aneurysms treated with the WEB device was made autonomously in each center by the interventional neuroradiologists according to aneurysm characteristics (aneurysm status, aneurysm location and size, neck size). Informed consent was obtained from all patients. The WEB device is illustrated in Figure 1 .
The device is composed of an inner and outer nitinol braid held together by proximal, middle, and distal radiopaque markers and creating 2 compartments: 1 distal and 1 proximal. The WEB implant is deployed similarly to endovascular coil systems through microcatheters with an internal diameter $ 0.027 in. The detachment system is electrothermal and instantaneous. The WEB received a CE Mark for unruptured and ruptured aneurysms.
Procedure
The treatment of aneurysms with the WEB was done using techniques similar to those used in the treatment of aneurysms with coils (eg, general anesthesia, intraoperative treatment with intravenous heparin, single or double femoral approach). Preoperative, intraoperative, and postoperative antiplatelet therapy was managed in each center as indicated for typical endovascular treatment with coils (or stent and coils if this approach was a potential alternative treatment).
After accurate evaluation of aneurysm anatomy (aneurysm morphology, aneurysm transverse diameter and height, and neck size) by the treating physician using magnetic resonance imaging and 2-dimensional and 3-dimensional digital subtraction angiography (DSA), it was determined whether treatment with WEB was indicated, along with appropriate device sizing.
After positioning of a guiding catheter into the internal carotid artery or vertebral artery, the aneurysm was catheterized with a Rebar 27 (Covidien/ev3, Irvine, California), Marksman 27 (Covidien/ev3), Headway 27 (Microvention, Tustin, California), DAC 038 (Concentric Medical, Mountain View, California), or Penumbra 41 (Penumbra, Alameda, California). The WEB device chosen according to aneurysm measurements was then positioned in the aneurysmal sac. A control angiogram was performed to check the position of the device in the aneurysm and to evaluate flow stagnation inside the aneurysm. If the position was not satisfactory, the device was resheathed and repositioned. If the size was not appropriate, the device was resheathed and another device was deployed into the aneurysm. When the right-sized device was correctly positioned, a final DSA run was performed. Treatment with ancillary devices (balloon, coils and stent) was performed if deemed necessary by the treating physician.
Follow-up of the patients was conducted according to the usual clinical practice of each center.
Data Collection
For each patient and aneurysm, the following data were collected: age, sex, aneurysm status (ruptured/unruptured), aneurysm location and size (transverse diameter and height), neck size, modalities of treatment (perioperative medications, associated treatment), intraoperative complications (aneurysm rupture, thromboembolic events, device problems), and postoperative complications (thromboembolic complications, delayed rupture).
The quality of the aneurysm occlusion was assessed by the treating physician by DSA at the end of the procedure and in the short-term follow-up.
Data Analysis
Population, feasibility of the treatment, rate of intraprocedural and postprocedural complications, morbidity (defined as modified Rankin Scale [mRS] score .1) and mortality at 1 month, and immediate and follow-up angiographic outcome were evaluated.
At the short-term follow-up (months), the quality of the aneurysm occlusion was evaluated using the 3-grade Montreal scale (total occlusion, neck remnant, aneurysm remnant).
RESULTS
Data on the patient and aneurysm population are given in Table 1 . From October 2010 to July 2012, 33 patients (28 women and 5 men) 35 to 77 years of age (mean, 55.8 6 10.0 years) harboring 34 MCA aneurysms were treated with the WEB device in 5 centers (14, 8, 5, 3 , and 3 patients in each center). One patient had 2 MCA aneurysms. Two aneurysms were ruptured and treated 1 day after the rupture. Three aneurysms were recanalized aneurysms after previous treatment with coiling. Twenty-nine aneurysms were unruptured aneurysms.
Aneurysm dome width was , 5 mm in 3 of the 34 aneurysms (8.8%), 5 to 10 mm in 29 aneurysms (85.3%), and . 10 mm in 2 cases (5.9%).
Neck size was , 4 mm in 4 of 34 aneurysms (11.8%) and $ 4 mm in 30 aneurysms (88.2%). Dome-to-neck ratio (transverse diameter/neck) was # 1.5 in 26 of the 34 aneurysms (76.5%) and . 1.5 in 8 aneurysms (23.5%).
Treatment Failure and Modalities
The WEB device was successfully deployed in 33 of the 34 aneurysms (97.1%). In 1 patient, the transverse diameter of the aneurysm was 5.5 mm, and neither the 6-mm-diameter device nor the 5-mm-diameter device was appropriate for aneurysm occlusion. The aneurysm was treated with stenting and coiling. This patient was excluded from further analyses.
All but 1 aneurysm were treated with 1 device. In 1 aneurysm, 2 devices were deployed inside the aneurysm.
No antiplatelet treatment was given during the treatment of 17 of 33 aneurysms (51.5%). Antiplatelet therapy was used in 16 of 33 aneurysms (48.5%): 1 agent in 10 cases and 2 agents in 6 cases.
The treatment was performed exclusively with the WEB device in 29 of 33 aneurysms (87.9%). Additional treatment was used in 4 aneurysms (12.1%), including coiling in 2 aneurysms and stenting in 2 aneurysms. In 1 previously coiled MCA, the size of the aneurysm remnant was very difficult to evaluate, and the device used was too small; 2 additional coils were deposited after deployment of the WEB. In another patient, the aneurysm ruptured during treatment, and the rupture was treated with coils and glue (see below). In 2 patients, stenting was used because there was a small protrusion of the device in the parent vessel. The adverse events and clinical status of the patients are given in Table 2 .
In 1 of 32 patients (3.1%), intraoperative rupture was observed after the WEB was deployed in a daughter sac. The rupture was treated rapidly with coils and glue with successful occlusion of the rupture site but with occlusion of 1 branch of the MCA bifurcation. The patient developed an ischemic lesion with hemiparesis. After 3 months, the patient still has a deficit and was evaluated as having an mRS score of 3.
In 5 of 32 patients (15.6%), thromboembolic events were observed. In 3 patients, events occurred under antiplatelet treatment (1 medication), whereas in 2 patients, no antiplatelet treatment was given. In 3 cases, events were noticed intraoperatively by DSA and treated with intra-arterial administration of thrombolytics, and no clinical worsening occurred (mRS score, 0 in the 3 patients). Thromboembolic events with clinical worsening were observed in 2 of 32 patients (6.3%). In 1 patient, the procedure was uneventful, but a transient hemiparesis was observed in the postoperative period. In another case, thrombus in an MCA branch was observed during the procedure and treated by intra-arterial administration of thrombolytics. Postoperatively, the patient had hemiparesis and vertigo, and magnetic resonance imaging showed an ischemic lesion in the pons, probably related to the diagnostic angiography performed before the endovascular treatment. At 1 month, the patient had an mRS score of 1. Finally, these 2 patients, although initially symptomatic, had mRS scores of 0 and 1 at 1 month. No treatment-related mortality was observed (0.0%). Treatment morbidity (mRS score $ 2) was encountered in 1 of the 32 patients (3.1%).
Midterm Aneurysm Occlusion and Retreatment
Midterm aneurysm occlusion was evaluated by DSA in 30 of 33 aneurysms (90.9%) 2 to 12 months after treatment (mean, 7. 
DISCUSSION
This preliminary series shows that WEB intrasaccular flow disruption is highly feasible in MCA aneurysms despite the use of a much larger microcatheter than usually used for coil embolization, with low morbidity and mortality and good anatomic results in midterm follow-up.
Preliminary animal studies concluded that treatment with the WEB device was associated with promising rates of immediateand long-term aneurysm occlusion in the rabbit elastase aneurysm model. 21 Angiographic aneurysm occlusion was evaluated at 1, 3, 6, and 12 months, and the study also included histopathological analysis.
In our selected series, the treatment was highly feasible (97.1%) with 1 failure in 1 aneurysm. The failure was due to the fact that the appropriate device size (5.5 mm in diameter) was not available. According to the size of the currently available devices (5-11 mm in diameter in 1-mm increments), the treated aneurysms (maximum diameter) were mostly between 5 and 10 mm (85.3%). In the great majority of cases (88.2%), the aneurysm neck was $ 4 mm, indicating that this device is uniquely appropriate for the treatment of wide-necked MCA aneurysms in the above range.
The porosity and conformability of the WEB treat aneurysms similar to an initial 3-dimensional or framing coil. Framing coils are often "up-sized" or "right-sized" on the basis of aneurysm width or diameter to achieve apposition against the aneurysm wall and to provide a beginning scaffold across the aneurysm neck. If the framing coil is too large or too small, it is withdrawn and another size is chosen. WEB aneurysm treatment is nearly identical to this treatment. The sizing recommendation is to average the available aneurysm widths and heights and to select a WEB that is 1 mm larger than the average width and 1 mm smaller than the average height. If the selected size is too large or too small, the WEB is withdrawn and a new size is selected and deployed. However, markedly different from a single framing coil but as a result of gentle compression of the 1-mm up-sized width, the WEB can be placed at the neck of the aneurysm, and if it does not fill the entire aneurysm volume (ie, blebs or additional height), the implant still provides effective contrast stasis and eventual thrombosis in those distal areas and the aneurysm overall.
Despite the very specific population (wide-necked MCA aneurysms) and the fact that this series includes the first cases treated with this new technique (ie, learning curve), the rate of adverse events was low. Intraoperative rupture was observed in 1 case (3.1%) at the beginning of the experience of 1 center (The device was inadvertently deployed in a daughter sac). In the Brinjikji et al 17 review of coiling of MCA aneurysms, the rate of intraoperative rupture was similar (3.1%). In the ATENA series dealing with unruptured aneurysms, intraoperative ruptures were observed in 2.6% of the procedures with a rate of 4.1% for MCA aneurysms.
3 WEB thromboembolic events were globally observed in 15.6% of cases with clinical events in only 2 patients (6.3%), with 1 event unrelated to the treatment but related to the preoperative DSA. The rate of thromboembolic events was slightly higher compared with what was reported in the ATENA series (7.1% for the global population and 9.6% for MCA aneurysms) but is quite similar to what was reported in the CLARITY series dealing with ruptured aneurysms (global rate of thromboembolic events: 13.3%, leading to permanent deficit in 3.2% and death in 1.0%). 2, 3 In the Brinjikji et al 17 review, morbidity and mortality resulting from thromboembolic complications were 3.2% and 0.6, respectively.
Despite this slightly higher rate of thromboembolic complications, clinical outcome at 1 month was satisfactory, with a mortality of 0.0% and a morbidity of 3.1%. These compare favorably with the mortality and morbidity of endovascular treatment of MCA aneurysms as reported in the Brinjikji et al 17 review (1.2% and 3.9%, respectively). In recent large neurosurgical series, the results of the endovascular treatment with the WEB are also acceptable. In a recent large series with 263 patients with 339 unruptured aneurysms, the mortality and morbidity of surgical clipping were 0.4% and 4.9%, respectively. 10 In another very recent series dealing with a high number of patients (543), surgical mortality and morbidity rates were 5.3% and 4.6%, respectively.
12
The occurrence of thromboembolic events was not linked to the antiplatelet treatment given to the patient because events occurred in 3 patients treated with 1 antiplatelet medication and in 2 patients receiving no antiplatelet treatment. The modalities of the antiplatelet treatment were quite heterogeneous in this series. Some patients were treated with 2 medications because a potential therapeutic option was stenting. In the other patients, antiplatelet treatment was used according to the current modalities of each center. Some centers are currently using peroperative and postoperative antiplatelet treatment when treating unruptured aneurysms, whereas other centers are not using any systematic antiplatelet treatment even for unruptured aneurysms.
Only short-term follow-up is available, and not in all patients (90.9%). Complete occlusion was observed in a relatively low percentage of aneurysms (26.7%), which is not really a surprise because most aneurysms have a complex shape. On the contrary, neck remnants were frequently observed (56.7%). This is due to the shape of the WEB and the type of aneurysms treated in this series. The proximal surface of the WEB is not flat but has a recess, which is concave from the direction of the parent artery. It was designed to minimize protrusion of the proximal marker in the parent vessel, but it contributes to the appearance of a neck remnant. A WEB neck remnant is likely fundamentally different from a coil remnant in that the exposed surface at the level of the neck is smooth compared with the irregular surface created by the coils. Of course, longer follow-up is needed to confirm that WEB neck remnants are stable and provide a durable aneurysm repair. Aneurysms treated in this series were mostly wide-necked aneurysms with MCA branches arising close to or at the neck. In some of these cases, the physician chose not to cover an MCA branch with the device to avoid thromboembolic events, thus creating a small neck remnant. Indeed, the evolution of these neck remnants in the midterm and long-term follow-up will be very important to analyze. However, it should be noted that adequate occlusion (complete occlusion or neck remnant) was obtained in a high percentage of cases (83.3%) and is the clinically relevant metric.
Standard endovascular treatment of MCA aneurysms with coils is particularly difficult when the neck is wide or when a branch arises close to or at the neck. In these situations, the remodeling technique can be an option using a hypercompliant balloon, a double-lumen balloon, or a double-balloon technique, but coil stabilization is not always feasible, particularly when the dome-to-neck ratio is unfavorable. 8 Single or double stenting may be proposed for these aneurysms, but its use is usually limited to unruptured aneurysms because of double antiplatelet therapy considerations. Moreover, intraluminal stenting increases the risk of parent artery stenosis and thrombosis. 22 In addition, because of the putative need for double antiplatelet therapy, the use of flow diverters is limited to unruptured aneurysms. 9 Because of the complex anatomy of the MCA bifurcation, the durable cure of the aneurysm is uncertain with the implantation of a single flow diverter. Moreover, preservation of the bifurcation branches and lenticulostriate arteries (if they are covered by the flow diverter) is relatively unpredictable. Indeed, surgical clipping is always an option for such complex MCA aneurysms but is more difficult to perform when the neck is wide, a branch is arising from the neck, or the wall is calcified around the neck. [10] [11] [12] Then, the number of options for these complex MCA aneurysms is relatively limited, and having a new endovascular technique for their treatment will certainly be helpful for the management of this group of patients.
Our study has limitations. First, the number of patients is relatively small, but it was important to report this preliminary evaluation of this very new endovascular approach for MCA aneurysm treatment because it may be an interesting option for complex lesions. Second, midterm and long-term follow-up is needed to evaluate the efficacy of this treatment in terms of aneurysm recanalization.
CONCLUSION
In our selected series of complex MCA aneurysms, intrasaccular flow disruption with the WEB device was feasible in a high percentage of aneurysms with acceptable morbidity and mortality and encouraging short-term anatomic results. This technique seems promising for the treatment of complex MCA aneurysms,good modality for the treatment of middle cerebral artery aneurysms, and it should be kept in mind as the endovascular WEB flow disruption gains traction.
Eric Sauvageau
Columbus, Ohio T he authors relate a series of 33 patients with 34 MCA aneurysms treated with the novel WEB device. Although favorable results of the use of this device in other types of aneurysms have previously been published, this article is a novel contribution to the literature in that it assesses the use of this device in the treatment of middle cerebral artery aneurysms. The results of this study are promising and bode well for further endovascular treatment of these complex aneurysms. Middle cerebral artery aneurysms are difficult to treat endovascularly because of their intimate association with the origins of the M2 branches and because these branches are frequently incorporated either on the aneurysm or in close proximity to the aneurysm neck. This device broadens the armamentarium of endovascular neurosurgeons in the treatment of what was once considered a primarily microsurgical disease. As with all novel devices, long-term follow-up, specifically assessing recurrence rates and potential changes of the affected parent arteries, will determine the true efficacy.
Felipe C. Albuquerque
Phoenix, Arizona W EB flow disruption is an example of a promising new endovascular technology that can be applied to aneurysms like middle cerebral artery (MCA) aneurysms long considered unfavorable for coiling on the basis of their trifurcated anatomy, broad necks, dysmorphic shapes, and angiographically undecipherable branches. The authors used WEB flow disruption to treat 34 wide-necked MCA aneurysms that would not have been treated well by simple coiling, thereby broadening the range of aneurysms accessible to the neurointerventionalist. Patients were favorably selected, with only 12% presenting with ruptured aneurysms and only 6% of the aneurysms . 10 mm. Complications included intraoperative rupture in 3% and thromboembolic events in 16%, but complete obliteration was achieved in only 27%. The mean 7-month follow-up period is within the time window when endovascular advantages in safety are evident but problems associated with efficacy, durability, rehemorrhage, recurrence, and retreatment have not surfaced yet. Therefore, we cannot conclude that WEB flow disruption has favorably affected the natural history of MCA aneurysms. MCA aneurysms have long been considered favorable for clipping because they are accessible, can be easily manipulated after splitting the Sylvian fissure, and avail themselves to other treatment techniques like thrombectomy, clip reconstruction, and bypass when conventional clipping techniques fail. The MCA aneurysm is the best example of an aneurysm with microsurgical results that are widely regarded as superior to endovascular results. Our experience with 631 MCA aneurysms in 543 patients demonstrated that microsurgery continues to yield excellent results with a wide spectrum of lesions and patients that included giant (5%), thrombotic (8%), and dolichoectatic (5%) aneurysms; ruptured aneurysms in poor-grade patients (11%); and aneurysms in older patients (. 65 years of age; 24%) 1 In our experience, 95% were clipped directly and 4% required bypass and trapping. Complete aneurysm obliteration was achieved in 98.3%, and 284 other aneurysms were clipped simultaneously. Outcomes were influenced more by ruptured presentation, Hunt-Hess grade, hemicraniectomy, and giant size than by surgical complications. To compare with WEB flow disruption results, morbidity and mortality for unruptured aneurysms are more appropriate and were 5.4% and 1.5%, respectively. There were no rehemorrhages or retreatments, and late angiographic follow-up (mean duration, 3.9 years) in 106 patients found no aneurysm recurrences.
From an evidence-based perspective, the preponderance of data still support microsurgical management of MCA aneurysms because of the capacity to treat all patients and all aneurysms with a variety of techniques, acceptably low morbidity/mortality, proven long-term durability, effective protection from aneurysm rupture, and approaches that are increasing minimally invasive. For now, the MCA aneurysm stands out as an example of how therapeutic management decisions can be based on aneurysm location alone. Patients are managed best when they are in specialized centers, receive care from dedicated experts, and have all treatment options available to them, including the latest new device. Still, they need straightforward recommendations from their neurosurgeons and other clinicians. Consensus supporting surgical clipping of MCA aneurysms is particularly strong, and clinicians should feel comfortable speaking with a clear and consistent voice that favors clipping for MCA aneurysms. In the meantime, new technology like WEB flow disruption should be rigorously studied to establish that endovascular results match surgical benchmarks before they are considered acceptable or even promising alternatives to surgery.
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